4 Articles
4 Articles
The high-tech center for the production of biological medicines is scheduled to be built in 2028.
The foundation stone for a new factory for the Ljubljana-based pharmaceutical company Lek, which is part of the Swiss Sandoz group, has been laid in Brnik. The investment is estimated at 400 million euros. The production of biosimilar drugs will take place on five hectares.
Lek will build a high-tech center for the production of similar biological medicines in Brnik. The investment is estimated at 400 million euros.
The foundation stone for a new factory for the Ljubljana-based pharmaceutical company Lek, which is part of the Swiss Sandoz group, will be laid in Brnik today. The investment is estimated to be worth around 400 million euros, and in addition to top representatives of Lek and Sandoz, the event will also be attended by Prime Minister Robert Golob and ambassadors from both countries.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium